HANGZHOU, China, Nov. 11, 2026 /PRNewswire/ -- Hangzhou Eli Radiopharma Co., Ltd. ("Eli Radiopharma", or "the Company"), an innovative radiopharmaceutical company focused on integrated diagnostics and therapeutics for oncology and neurological diseases, today announced the completion of a...
Hence then, the article about eli radiopharma completes series a financing of nearly rmb 400 million to advance innovative radiopharmaceutical pipeline toward clinical development was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Eli Radiopharma Completes Series A Financing of Nearly RMB 400 Million to Advance Innovative Radiopharmaceutical Pipeline Toward Clinical Development )
Also on site :
- DistroKid and Kobalt Partner on New Publishing Service for DIY Talent
- In 1999, a 25-year-old started a makeup brand with $250,000 from her parents; 15 years later, she sold it to L’Oréal for roughly $400 million
- Taylor Swift Will Be Honored With The Hollywood Reporter’s Sherry Lansing Leadership Award at Women in Entertainment Gala